The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Brandon Richard Folkes - Cantor Fitzgerald & Co., Research Division - Analyst
: Congratulations on another good quarter. Granted, you obviously sound quite confident on the Tyvaso DPI approval, but how should we think
about OpEx spending just in the case where Tyvaso DPI does not get approved this month, perhaps pushed out a little bit? Just any color in terms
of how we should think about maybe some levers in your current OpEx spend that may come down.
And then secondly, maybe just on Afrezza. Can you just elaborate -- and I apologize if I missed this, but where was wholesale inventory at the end
of this quarter?
Question: Brandon Richard Folkes - Cantor Fitzgerald & Co., Research Division - Analyst
: Great. And one more, if I may. Obviously, just with that very strong cash balance you have, how do you think about maybe bringing and licensing
a few more pipeline products? Obviously, you've bought a pretty robust pipeline. But I guess, do you have the capacity maybe, asked a different
way, to bring in additional products just given valuations for -- and licensing maybe coming down?
Question: Brandon Richard Folkes - Cantor Fitzgerald & Co., Research Division - Analyst
: Congrats again.
Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst
: Michael and Steve, congratulations on the progress. Maybe just building on the previous question, with respect to Tyvaso DPI decision coming
up, and maybe just around scenario planning. I think you answered the question just around OpEx. I'm just curious how the various scenarios
playing out whether, of course, if approval, but as mentioned, delay or otherwise, how you think about the potential permutations of your strategy,
the earlier mention of business development. Are there accelerants that we would see or other things to contemplate with respect to that decision
coming, with Tyvaso coming up?
|
